{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:38:24Z","timestamp":1793824704127,"version":"4.6.1"},"reference-count":50,"publisher":"BMJ","issue":"7","funder":[{"name":"Takeda Pharmaceutical Company Limited","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["11B8920N"],"award-info":[{"award-number":["11B8920N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["11C2219N"],"award-info":[{"award-number":["11C2219N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1289225N"],"award-info":[{"award-number":["1289225N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["12V3619N"],"award-info":[{"award-number":["12V3619N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G.0929.15"],"award-info":[{"award-number":["G.0929.15"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["W001620N"],"award-info":[{"award-number":["W001620N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010890","name":"Chinese Government Scholarship","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100010890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["C14\/18\/086"],"award-info":[{"award-number":["C14\/18\/086"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2008727"],"award-info":[{"award-number":["APP2008727"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012220","name":"Hercules Foundation","doi-asserted-by":"publisher","award":["AKUL\/15\/37_GOH1816N"],"award-info":[{"award-number":["AKUL\/15\/37_GOH1816N"]}],"id":[{"id":"10.13039\/100012220","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2025,2,11]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mast cell activation is an important driver of abdominal pain in irritable bowel syndrome (IBS). While evidence supports the role of IgE-mediated mast cell activation in visceral pain development in IBS, the role of pseudoallergic MRGPRX2-mediated mast cell activation in this process remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We investigated whether MRGPRX2-mediated mast cell activation plays a role in abdominal pain development in patients with IBS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>\n                      MRGPRX2 expression in mast cells and other immune cells was characterised across colon layers using flow cytometry. We evaluated whether MRGPRX2 agonists trigger mast cell degranulation and transient receptor potential vanilloid 1 (TRPV1) sensitisation in healthy human colonic submucosal plexus samples using live imaging. Rectal biopsies were then collected from patients with IBS and healthy volunteers (HV) and MRGPRX2\n                      <jats:sup>+<\/jats:sup>\n                      mast cell frequency, MRGPRX2 expression per cell, mast cell degranulation kinetics in response to MRGPRX2 agonists, MRGPRX2 agonistic activity and presence of MRGPRX2 agonists in biopsy supernatants were assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      MRGPRX2\n                      <jats:sup>+<\/jats:sup>\n                      mast cells are enriched in the submucosa and muscularis of the healthy human colon. MRGPRX2 agonists induce mast cell degranulation and TRPV1 sensitisation in the healthy colon submucosa. While the frequency of rectal MRGPRX2\n                      <jats:sup>+<\/jats:sup>\n                      mast cells was unaltered in IBS, submucosal mast cells showed increased degranulation in response to MRGPRX2 agonists in IBS compared with HV. MRGPRX2 agonistic activity was increased in IBS rectal biopsy supernatant compared with HV, which was associated with increased levels of substance P.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The MRGPRX2 pathway is functionally upregulated in the colon of patients with IBS, supporting its role in abdominal pain in IBS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2024-334037","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T13:20:30Z","timestamp":1740316830000},"page":"1068-1077","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["Characterisation of MRGPRX2\n                    <sup>+<\/sup>\n                    mast cells in irritable bowel syndrome"],"prefix":"10.1136","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5366-1262","authenticated-orcid":false,"given":"Lisse","family":"Decraecker","sequence":"first","affiliation":[{"name":"Center for Intestinal Neuroimmune Interactions, Translational Research in GastroIntestinal Disorders (TARGID), Chronic Diseases, Metabolism, and Ageing (CHROMETA), KU Leuven Biomedical Sciences Group, Leuven, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Cuende Est\u00e9vez","sequence":"additional","affiliation":[{"name":"Center for Intestinal Neuroimmune Interactions, Translational Research in GastroIntestinal Disorders (TARGID), Chronic Diseases, Metabolism, and Ageing (CHROMETA), KU Leuven Biomedical Sciences Group, Leuven, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Van Remoortel","sequence":"additional","affiliation":[{"name":"Center for Intestinal Neuroimmune Interactions, Translational Research in GastroIntestinal Disorders (TARGID), Chronic Diseases, Metabolism, and Ageing (CHROMETA), KU Leuven Biomedical Sciences Group, Leuven, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runze","family":"Quan","sequence":"additional","affiliation":[{"name":"Center for Intestinal Neuroimmune Interactions, Translational Research in GastroIntestinal Disorders (TARGID), Chronic Diseases, Metabolism, and Ageing (CHROMETA), KU Leuven Biomedical Sciences Group, Leuven, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6229-0045","authenticated-orcid":false,"given":"Nathalie","family":"Stakenborg","sequence":"additional","affiliation":[{"name":"Center for Intestinal Neuroimmune Interactions, Translational Research in GastroIntestinal Disorders (TARGID), Chronic Diseases, Metabolism, and Ageing (CHROMETA), KU Leuven Biomedical Sciences Group, Leuven, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Intestinal Neuroimmune Interactions, Translational Research in GastroIntestinal Disorders (TARGID), Chronic Diseases, Metabolism, and Ageing (CHROMETA), KU Leuven Biomedical Sciences Group, Leuven, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"De Marco","sequence":"additional","affiliation":[{"name":"Center for Intestinal Neuroimmune Interactions, Translational Research in GastroIntestinal Disorders (TARGID), Chronic Diseases, Metabolism, and Ageing (CHROMETA), KU Leuven Biomedical Sciences Group, Leuven, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Denadai-Souza","sequence":"additional","affiliation":[{"name":"Center for Intestinal Neuroimmune Interactions, Translational Research in GastroIntestinal Disorders (TARGID), Chronic Diseases, Metabolism, and Ageing (CHROMETA), KU Leuven Biomedical Sciences Group, Leuven, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francesca","family":"Viola","sequence":"additional","affiliation":[{"name":"Center for Intestinal Neuroimmune Interactions, Translational Research in GastroIntestinal Disorders (TARGID), Chronic Diseases, Metabolism, and Ageing (CHROMETA), KU Leuven Biomedical Sciences Group, Leuven, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Garcia Caraballo","sequence":"additional","affiliation":[{"name":"Visceral Pain Research Group, Hopwood Centre for Neurobiology, Lifelong Health Theme, South Australian Health and Medical Research Institute Limited, Adelaide, South Australia, Australia"},{"name":"Faculty of Health and Medical Sciences, The University of Adelaide - North Terrace Campus, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Brierley","sequence":"additional","affiliation":[{"name":"Visceral Pain Research Group, Hopwood Centre for Neurobiology, Lifelong Health Theme, South Australian Health and Medical Research Institute Limited, Adelaide, South Australia, Australia"},{"name":"Faculty of Health and Medical Sciences, The University of Adelaide - North Terrace Campus, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Tsukimi","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceutical Company Limited, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Hicks","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceutical Company Limited, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Winchester","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceutical Company Limited, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Wykosky","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceutical Company Limited, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Fanjul","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceutical Company Limited, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Gibson","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceutical Company Limited, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Wouters","sequence":"additional","affiliation":[{"name":"Center for Intestinal Neuroimmune Interactions, Translational Research in GastroIntestinal Disorders (TARGID), Chronic Diseases, Metabolism, and Ageing (CHROMETA), KU Leuven Biomedical Sciences Group, Leuven, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0009-2094","authenticated-orcid":false,"given":"Pieter","family":"Vanden Berghe","sequence":"additional","affiliation":[{"name":"Laboratory for Enteric Neuroscience (LENS), Translational Research in GastroIntestinal Disorders (TARGID), Chronic Diseases, Metabolism, and Ageing (CHROMETA), KU Leuven Biomedical Sciences Group, Leuven, Flanders, Belgium, KU Leuven, Leuven, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6309-8242","authenticated-orcid":false,"given":"Hind","family":"Hussein","sequence":"additional","affiliation":[{"name":"Center for Intestinal Neuroimmune Interactions, Translational Research in GastroIntestinal Disorders (TARGID), Chronic Diseases, Metabolism, and Ageing (CHROMETA), KU Leuven Biomedical Sciences Group, Leuven, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8267-5797","authenticated-orcid":false,"given":"Guy","family":"Boeckxstaens","sequence":"additional","affiliation":[{"name":"Center for Intestinal Neuroimmune Interactions, Translational Research in GastroIntestinal Disorders (TARGID), Chronic Diseases, Metabolism, and Ageing (CHROMETA), KU Leuven Biomedical Sciences Group, Leuven, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,23]]},"reference":[{"key":"2025121303232910000_74.7.1068.1","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2019-101298"},{"key":"2025121303232910000_74.7.1068.2","first-page":"S1","article-title":"Review article: epidemiology of IBS and other bowel disorders of gut-brain interaction (DGBI)","volume":"54 Suppl 1","author":"Sperber","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121303232910000_74.7.1068.3","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S40245"},{"key":"2025121303232910000_74.7.1068.4","first-page":"2986","article-title":"Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis","volume":"23","author":"Flacco","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2025121303232910000_74.7.1068.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02524.x"},{"key":"2025121303232910000_74.7.1068.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.12.005"},{"key":"2025121303232910000_74.7.1068.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.02066.x"},{"key":"2025121303232910000_74.7.1068.8","doi-asserted-by":"publisher","DOI":"10.5056\/jnm16001"},{"key":"2025121303232910000_74.7.1068.9","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90267-8"},{"key":"2025121303232910000_74.7.1068.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.05984.x"},{"key":"2025121303232910000_74.7.1068.11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-020518-114525"},{"key":"2025121303232910000_74.7.1068.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00700-9"},{"key":"2025121303232910000_74.7.1068.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2011.03.019"},{"key":"2025121303232910000_74.7.1068.14","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33579"},{"key":"2025121303232910000_74.7.1068.15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.11.039"},{"key":"2025121303232910000_74.7.1068.16","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.192567"},{"key":"2025121303232910000_74.7.1068.17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.11.055"},{"key":"2025121303232910000_74.7.1068.18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12618-7","article-title":"Evidence for long-term sensitization of the bowel in patients with post-infectious-IBS","volume":"7","author":"Balemans","year":"2017","journal-title":"Sci Rep"},{"key":"2025121303232910000_74.7.1068.19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.12.034"},{"key":"2025121303232910000_74.7.1068.20","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-331634"},{"key":"2025121303232910000_74.7.1068.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03118-2"},{"key":"2025121303232910000_74.7.1068.22","doi-asserted-by":"publisher","DOI":"10.1038\/nri3427"},{"key":"2025121303232910000_74.7.1068.23","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12629"},{"key":"2025121303232910000_74.7.1068.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2023.02.002"},{"key":"2025121303232910000_74.7.1068.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2019.01.012"},{"key":"2025121303232910000_74.7.1068.26","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.23.040183.001555"},{"key":"2025121303232910000_74.7.1068.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.08.177"},{"key":"2025121303232910000_74.7.1068.28","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12655","article-title":"Endogenous protein and enzyme fragments induce immunoglobulin E-independent activation of mast cells via a G protein-coupled receptor, MRGPRX2","volume":"87","author":"Tatemoto","year":"2018","journal-title":"Scand J Immunol"},{"key":"2025121303232910000_74.7.1068.29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI90361"},{"key":"2025121303232910000_74.7.1068.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.03.049"},{"key":"2025121303232910000_74.7.1068.31","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13579","article-title":"Expression of immune\u2010related genes in rectum and colon descendens of Irritable Bowel Syndrome patients is unrelated to clinical symptoms","volume":"31","author":"Aguilera\u2010Lizarraga","year":"2019","journal-title":"Neurogastroenterology Motil"},{"key":"2025121303232910000_74.7.1068.32","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301777"},{"key":"2025121303232910000_74.7.1068.33","doi-asserted-by":"publisher","DOI":"10.4161\/cc.28401"},{"key":"2025121303232910000_74.7.1068.34","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"2025121303232910000_74.7.1068.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.01.012"},{"key":"2025121303232910000_74.7.1068.36","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230570","article-title":"Landscape of mast cell populations across organs in mice and humans","volume":"220","author":"Tauber","year":"2023","journal-title":"J Exp Med"},{"key":"2025121303232910000_74.7.1068.37","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb7221","article-title":"Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation","volume":"6","author":"Dwyer","year":"2021","journal-title":"Sci Immunol"},{"key":"2025121303232910000_74.7.1068.38","doi-asserted-by":"crossref","unstructured":"Hussein H , Modave E , Stakenborg N , et al . Single cell transcriptomics reveal mast cell heterogeneity in the human gut. Immunology [Preprint] 2024. doi:10.1101\/2024.11.29.626054","DOI":"10.1101\/2024.11.29.626054"},{"key":"2025121303232910000_74.7.1068.39","doi-asserted-by":"publisher","DOI":"10.1111\/all.14213"},{"key":"2025121303232910000_74.7.1068.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.01.029"},{"key":"2025121303232910000_74.7.1068.41","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00542.2011"},{"key":"2025121303232910000_74.7.1068.42","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0493-z"},{"key":"2025121303232910000_74.7.1068.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2023.100579"},{"key":"2025121303232910000_74.7.1068.44","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00358.2003"},{"key":"2025121303232910000_74.7.1068.45","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.181701"},{"key":"2025121303232910000_74.7.1068.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbrainres.2004.10.007"},{"key":"2025121303232910000_74.7.1068.47","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M302456200"},{"key":"2025121303232910000_74.7.1068.48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1026304","article-title":"Mas-related G protein-coupled receptor MRGPRX2 in human basophils: Expression and functional studies","volume":"13","author":"Toscano","year":"2022","journal-title":"Front Immunol"},{"key":"2025121303232910000_74.7.1068.49","doi-asserted-by":"crossref","DOI":"10.1002\/ski2.195","article-title":"Elevated, Fc\u03b5RI-dependent MRGPRX2 expression on basophils in chronic urticaria","volume":"3","author":"Bartko","year":"2023","journal-title":"Skin Health Dis"},{"key":"2025121303232910000_74.7.1068.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.04.051"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2024-334037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T11:23:42Z","timestamp":1765625022000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2024-334037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,23]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,6,6]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/gutjnl-2024-334037"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2024-334037","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,23]]}}}